Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers

Int J Cardiol Heart Vasc. 2021 Dec 1:37:100924. doi: 10.1016/j.ijcha.2021.100924. eCollection 2021 Dec.

Jordi Heijman¹, Ann-Kathrin Rahm², Dobromir Dobrev^{3

4

5}

¹ Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine, and Life Sciences, Maastricht University and Maastricht UMC+, Maastricht, the Netherlands.
² Department of Cardiology and Heidelberg Center for Heart Rhythm Disorders (HCR), University Hospital Heidelberg and German Centre for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany.
³ Institute of Pharmacology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
⁴ Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX, United States.
⁵ Departments of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Canada.

No abstract available

Publication types